Paul Giannasca PhD

Paul is responsible for developing R&D strategies as well as building and managing the GI Health pipeline, which leverages various nutritional and technological platforms. Paul has over 20 years of research and development experience in vaccines and infectious diseases and most recently served as VP of development at Genocea Biosciences.

Previously, he was the Project Leader for the C. difficile vaccine program at Acambis and Sanofi Pasteur. Paul received his PhD in Molecular and Cellular Biology from the University of Massachusetts-Amherst and completed post-doctoral training in mucosal immunology and enteric infections at Harvard Medical School.